Abiopharma

NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction and Delisting Date of Kadimastems Shares

Becoming a substantial holder

LEVI & KORSINSKY ISSUES CORRECTION: Securities Fraud Class Action Against Savara Inc.

Rosen Law Firm Encourages AVITA Medical, Inc. Investors to Inquire About Securities Class Action Investigation – RCEL

U.S. Centers for Medicare & Medicaid Services finalizes National Coverage Determination for the Medtronic Symplicity Spyral™ renal denervation (RDN) system

Nektar to Announce Financial Results for the Third Quarter on Thursday, November 6, 2025, After Close of U.S.-Based Financial Markets

GENFIT Announces Advances Across its ACLF Pipeline at AASLD The Liver Meeting® 2025

QIAGEN Marks 4,000th QIAcube Connect Placement, Reaffirming Leadership in Automated Sample Processing

Rapid Micro Biosystems to Announce Third Quarter 2025 Financial Results on November 7, 2025

Tarsus to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025